Xiushentang (08200) announced that on April 8, 2024, the group acquired a total of 15 million shares of the target company through intra-market transactions carried out on the Stock Exchange at a total cost of about HK$8.95 million (not including transaction costs), which is equivalent to approximately HK$0.60 per share.
During the 12-month period prior to the date of the target company's acquisition, the group acquired a total of 1.3 million shares of the target company at a total cost of approximately HK$923,900 (not including transaction costs). The target company is Clarity Medical Group Holdings Limited (01406).
Following the acquisition of the target company, the group held a total of 16.3 million shares of the target company, which is equivalent to approximately 3.09% of the target company's total issued share capital on the date of this announcement (calculated that 528 million shares of the target company were issued on March 31, 2024, according to publicly available information).